Reply to Aitken et al., "Should Piperacillin-Tazobactam Be Used as Definitive Therapy against Enterobacteriaceae Harboring Inducible AmpC beta-Lactamases?"
- 浏览0
Antimicrobial agents and chemotherapy.
e01163-17-e01163-17页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



